A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis. This is the ...

Nirsevimab implementation in Catalonia, Spain, reduced emergency department visits and hospital admissions for bronchiolitis ...

A single injection of nirsevimab, a long-acting monoclonal antibody developed to prevent respiratory syncytial virus (RSV) ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug ...

Pediatric research explored environmental interventions for bronchiolitis, heart function in children born preterm, and a ...

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar ...

The 9-year-old Harborcreek Township girl used to run around with the other kids on the Rolling Ridge Elementary School ...

A panelist discusses how axatilimab is particularly effective for patients with bronchiolitis obliterans syndrome, showing ...

Respiratory Syncytial Virus (RSV) poses a significant threat to Indian infants, particularly during post-monsoon and winter, ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.